Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

4D Molecular Therapeutics Inc (FDMT)

4D Molecular Therapeutics Inc (FDMT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Markets Today: Stocks Slip on Hawkish Fed Comments

Morning Markets March E-Mini S&P 500 futures (ESH24 ) are down -0.30%, and March Nasdaq 100 E-Mini futures (NQH24 ) are down -0.19%. Stock index futures this morning are mildly lower as higher bond yields...

ESZ24 : 5,737.75 (-0.10%)
NQZ24 : 20,062.75 (-0.12%)
BA : 155.07 (+0.31%)
APD : 306.09 (-1.01%)
ZS : 184.90 (+1.27%)
MAT : 20.01 (+0.50%)
CYTK : 51.48 (-0.66%)
GWW : 1,095.68 (-0.85%)
CAT : 376.52 (-0.82%)
EL : 66.45 (-0.20%)
FDMT : 8.18 (+0.99%)
CTLT : 58.69 (-0.07%)
Stocks Set to Open Lower as Investors Weigh Powell’s Remarks, Earnings and Fed Speak in Focus

March S&P 500 E-Mini futures (ESH24) are down -0.24%, and March Nasdaq 100 E-Mini futures (NQH24) are down -0.12% this morning as U.S. Treasury yields climbed on relatively hawkish comments from Federal...

ESH24 : 5,101.67s (-1.01%)
NQH24 : 17,854.75s (-0.94%)
META : 560.68 (-1.14%)
EW : 66.47 (-1.58%)
AMZN : 195.78 (-1.09%)
CHTR : 375.83 (+2.55%)
MCD : 292.85 (-0.80%)
CAT : 376.52 (-0.82%)
LLY : 806.14 (-1.56%)
F : 10.36 (+1.37%)
AMGN : 316.91 (-0.72%)
DIS : 95.79 (-0.02%)
Astellas and 4D Molecular Therapeutics (4DMT) Enter into License Agreement to Use 4DMT's Proprietary Intravitreal R100 Vector for Rare Ophthalmic Targets

/PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503) (President and CEO: Naoki Okamura, "Astellas") and 4D Molecular Therapeutics, Inc. (NASDAQ: FDMT) (CEO: David...

FDMT : 8.18 (+0.99%)
Markets Today: Stocks Higher as Bond Yields Fall on Jobless Claims Surge

Morning Markets June E-Mini S&P 500 futures (ESM2 3) this morning are up +0.03%, and June Nasdaq 100 E-Mini futures (NQM2 3) are up +0.16%. U.S. stock index futures this morning recovered from overnight...

ESZ24 : 5,737.75 (-0.10%)
NQZ24 : 20,062.75 (-0.12%)
SMTC : 43.92 (-1.39%)
ADBE : 481.35 (-0.30%)
ALV : 94.97 (-0.21%)
IGT : 20.32 (-1.12%)
REVG : 27.03 (+2.58%)
TCOM : 67.24 (+3.14%)
FDMT : 8.18 (+0.99%)
SIG : 91.17 (-0.96%)
OXM : 73.08 (+0.27%)
SMAR : 55.88 (-0.66%)
Stocks Little Changed Before the Open as Investors Weigh Interest Rate Outlook

June S&P 500 futures (ESM23) are up +0.05%, and June Nasdaq 100 E-Mini futures (NQM23) are up +0.15% this morning after three major U.S. benchmark indices finished the regular session mixed as an unexpected...

ESM23 : 4,453.35s (+0.61%)
NQM23 : 15,316.61s (+0.85%)
CPB : 46.38 (+0.11%)
MCHP : 74.47 (-0.45%)
NXPI : 236.90 (-0.71%)
WBD : 8.17 (-0.73%)
WIZZ.LN : 1,368.000 (-0.73%)
GME : 22.33 (-0.36%)
HCP : 33.83 (-0.27%)
EXPI : 13.50 (+1.43%)
CURV : 3.57 (-0.83%)
FDMT : 8.18 (+0.99%)
2 Biotech Stocks That Can Rocket Higher in 2023, According to Wall Street

Recent analyst upgrades suggest these stocks can triple your money or better.

ARDX : 5.89 (-3.28%)
FDMT : 8.18 (+0.99%)
4D Molecular Therapeutics to Participate in Upcoming June Investor Conferences

EMERYVILLE, Calif., June 02, 2022 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics, Inc. (Nasdaq: FDMT), a clinical-stage biotherapeutics company harnessing...

FDMT : 8.18 (+0.99%)
4D Molecular Therapeutics Reports First Quarter 2022 Financial Results and Provides Corporate Updates

EMERYVILLE, Calif., May 12, 2022 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics, Inc. (Nasdaq: FDMT), a clinical-stage biotherapeutics company harnessing...

FDMT : 8.18 (+0.99%)
4D Molecular Therapeutics to Participate in the BofA Securities 2022 Healthcare Conference

EMERYVILLE, Calif., May 05, 2022 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics, Inc. (Nasdaq: FDMT), a a clinical-stage biotherapeutics company...

FDMT : 8.18 (+0.99%)
4D Molecular Therapeutics Announces First Patient Dosed in Phase 1/2 Clinical Trial of 4D-710, an A101 AAV Vector-based, Aerosol-delivered Genetic Medicine for the Treatment of Cystic Fibrosis

EMERYVILLE, Calif., April 04, 2022 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics, Inc. (4DMT) (Nasdaq: FDMT), a clinical-stage biotherapeutics company...

FDMT : 8.18 (+0.99%)

Barchart Exclusives

Is This High-Yield Dividend Stock a Buy After Earnings?
This pharmaceutical giant's Q3 numbers came in ahead of Street estimates. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar